ReviewBMC cancer2021

Multicenter randomized controlled trial and registry study to assess the safety and efficacy of the NanoKnife® system for the ablation of stage 3 pancreatic adenocarcinoma: overview of study protocols.

Govindarajan Narayanan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.